Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
migraine
Biotech
Impel seeks loan leniency to avoid asset sale or bankruptcy
Impel warned it may have to sell assets or file for bankruptcy if it is unable to restructure its credit deal and secure fresh funding.
Nick Paul Taylor
Aug 16, 2023 8:09am
Theranica earns updated CE mark for migraine-easing armband
Aug 10, 2023 2:50pm
With skin in the game, Satsuma's partner offers buyout
Apr 17, 2023 8:31am
Satsuma peels off staff, cutting head count by 36% to save cash
Mar 29, 2023 6:30am
Theranica's migraine tech expands into prevention with FDA nod
Mar 1, 2023 10:40am
Click Therapeutics nets FDA breakthrough nod for migraine app
Dec 19, 2022 12:13pm